In this context, understanding the mechanisms harnessed by cells with supernumerary centrosomes to bypass CASP2-mediated oncosuppression beyond p53, CASP2, and ANKRD26 defects12,14 will shed additional light on the capacity of malignant cells to tolerate aneuploidy and potentially guide the design of novel therapeutic strategies against cancer. Here, CASP2 is linked to cancer.